ArticleHuman vaccines & immunotherapeutics2017

A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks.

Georgi Shukarev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.